StockData
Natures Sunshine Products Inc logo

Natures Sunshine Products Inc (NATR) stock

NATRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3058% below fair value
$10.33−0.23 (-2.18%)

Close on Nov 17, 2026Market cap $181.76MP/E 10.2Yield –

Natures Sunshine Products total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Natures Sunshine Products's total debt was $0 at Dec 31, 2023. For fiscal 2023 it was $0, down 100.0% from the year before. The highest annual figure on record is $12.27M in fiscal 2013.

Annual total debt

PeriodPeriod endValueChange
FY2023Dec 31, 2023$0-100.0%
FY2022Dec 31, 2022$1.17M-51.4%
FY2021Dec 31, 2021$2.42M-35.1%
FY2020Dec 31, 2020$3.72M–
FY2019Dec 31, 2019$0–
FY2017Dec 31, 2017$0-100.0%
FY2016Dec 31, 2016$9.92M+267.9%
FY2015Dec 31, 2015$2.70M–
FY2014Dec 31, 2014$0-100.0%
FY2013Dec 31, 2013$12.27M+118.3%
FY2012Dec 31, 2012$5.62M-38.8%
FY2011Dec 31, 2011$9.19M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2023Dec 31, 2023$0-100.0%
Q1 FY2023Mar 31, 2023$1.01M-52.3%
Q4 FY2022Dec 31, 2022$1.17M-51.4%
Q3 FY2022Sep 30, 2022$1.49M-45.4%
Q2 FY2022Jun 30, 2022$1.80M-40.5%
Q1 FY2022Mar 31, 2022$2.11M-36.6%
Q4 FY2021Dec 31, 2021$2.42M-35.1%
Q3 FY2021Sep 30, 2021$2.72M-49.3%
Q2 FY2021Jun 30, 2021$3.03M-43.7%
Q1 FY2021Mar 31, 2021$3.33M–
Q4 FY2020Dec 31, 2020$3.72M–
Q3 FY2020Sep 30, 2020$5.37M-45.8%
Q2 FY2020Jun 30, 2020$5.37M–
Q4 FY2019Dec 31, 2019$0–
Q4 FY2017Dec 31, 2017$0–
Q4 FY2016Dec 31, 2016$9.92M–

More Natures Sunshine Products figures

See a number that looks wrong?